RxDoctor Payments Data

Sana Akbar

Endocrinology, Diabetes & Metabolism · Greenbelt, MDNPI 1922448604

Payments from drug & device makers

$2,717in general payments, 2019–2025

Across 129 payments — averaging $21.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$674
  • Lilly USA, LLC$347
  • Insulet Corporation$272
  • Xeris Pharmaceuticals, Inc.$194
  • Amneal Pharmaceuticals LLC$166
  • Sanofi-aventis U.S. LLC$161
  • plus $904 from 17 others

What the payments were for

  • Food & beverage$2,70399%
  • Education$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,717 in reported general payments places this provider in the 60th percentile of 235 endocrinology, diabetes & metabolism providers in Maryland.

See all endocrinology, diabetes & metabolism providers in Maryland

Other endocrinology, diabetes & metabolism in Greenbelt

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →